93 related articles for article (PubMed ID: 2516011)
1. Slow thaw siphon technique for cryoprecipitate production.
Chudgar UH; Chandy M; Pulimood RB; Khanduri U
Indian J Med Res; 1989 Aug; 90():295-9. PubMed ID: 2516011
[TBL] [Abstract][Full Text] [Related]
2. In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparations.
Toolis F; McKay G; Prowse CV
Thromb Haemost; 1980 Feb; 43(1):25-7. PubMed ID: 6773169
[TBL] [Abstract][Full Text] [Related]
3. An improved thaw-siphon method for the cryoprecipitate preparation.
Kang EP
Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
[TBL] [Abstract][Full Text] [Related]
4. Lyophilized cryoprecipitate for children with hemophilia A.
Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
[TBL] [Abstract][Full Text] [Related]
5. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
[TBL] [Abstract][Full Text] [Related]
6. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
[TBL] [Abstract][Full Text] [Related]
7. Thawed cryoprecipitate stored for 6 h at room temperature: a potential alternative to factor VIII concentrate for continuous infusion.
Pesquera-Lepatan LM; Hernandez FG; Lim RD; Chua MN
Haemophilia; 2004 Nov; 10(6):684-8. PubMed ID: 15569162
[TBL] [Abstract][Full Text] [Related]
8. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
[TBL] [Abstract][Full Text] [Related]
9. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
Mason EC; Pepper DS; Griffin B
Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
[TBL] [Abstract][Full Text] [Related]
10. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
[TBL] [Abstract][Full Text] [Related]
12. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
[TBL] [Abstract][Full Text] [Related]
13. Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII.
Mason EC
Lancet; 1978 Jul; 2(8079):15-7. PubMed ID: 78212
[TBL] [Abstract][Full Text] [Related]
14. A novel modified thaw-siphon method for extracting cryoprecipitate: The Bokutoh-siphon method.
Nishimura S; Teratani M; Igarashi T; Nakahara M; Hazama Y; Ohtani S; Fujita H
Transfusion; 2021 Apr; 61(4):1035-1040. PubMed ID: 33634868
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
[TBL] [Abstract][Full Text] [Related]
16. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
[TBL] [Abstract][Full Text] [Related]
17. A high-potency, single-donor cryoprecipitate of known factor VIII content dispensed in vials.
McLeod BC; Sassetti RJ; Cole ER; Scott JP
Ann Intern Med; 1987 Jan; 106(1):35-40. PubMed ID: 3098152
[TBL] [Abstract][Full Text] [Related]
18. Preparation of pooled cryoprecipitate for treatment of hemophilia A in a home care program.
Smith KJ; Hodges PA
Transfusion; 1984; 24(6):520-3. PubMed ID: 6438840
[TBL] [Abstract][Full Text] [Related]
19. Use of 'single donor' factor VIII from plasma exchange donation.
McLeod BC; Scott JP
JAMA; 1984 Nov; 252(19):2726-9. PubMed ID: 6436520
[TBL] [Abstract][Full Text] [Related]
20. Can storage of thawed cryoprecipitate be extended to more than six hours?
Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA
Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
